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LC/MS Method for the Determination of Stable Isotope Labeled 
Promethazine in Human Plasma 
Analyte 
Promethazine-dO 
Promethazine-d4 
Promethazine-d7 
$ Zuwei Wang', Jason Boyd , Kurt L. Berens' and Lakshmi Putcha" 
Linear Range LOQ cv (%) 
(ng/ml) Inter-day Intra-day 
1-100 1 .oo < 5.4 < 4.5 
1-100 1 .oo < 6.6 < 6.8 
0.5-100 0.50 < 6.5 < 7.5 
* NASA Johnson Space Center, Houston, TX, + Wyle Laboratories, Life Sciences 
Systems and Services and USRA, Houston, TX 77058 $ 
Purpose: Promethazine (PMZ) is taken by astronauts orally (PO), intramuscularly (IM) 
or rectally (PR) for space motion sickness. We developed an LCMS method with off-line 
solid phase extraction to measure plasma concentrations of PMZ given as stable isotope- 
labeled (SIL) formulations by the three different routes of administration simultaneously. 
Method: Samples (0.5ml) were loaded on to Waters Oasis HLB co-polymer cartridges 
and eluted with 1.0 mL methanol. HPLC separation of the eluted sample was performed 
using an Agilent Zorbax SB-CN column (50 x 2.1 mm) at a flow rate of 0.2 mL/min for 6 
min. Acetonitrile/ ammonium acetate (30 mh4) in water (3:2, v/v), pH 5.6 f 0.1, was used 
as the mobile phase for separation. Concentrations of PMZ, PMZ-d4 and PMZ-d7 and 
chlorpromazine (internal standard) were determined using a Micromass ZMD single 
quadrupole mass spectrometer with Electrospray Ionization (ESI). ESI mass spectra were 
acquired in positive ion mode with selected ion monitoring of [M+H]+. 
Results: The method is rapid, reproducible and the assay specific parameters are listed in 
the following table. 
Conclusion: We report a novel, sensitive and specific method for the measurement of 
PMZ and SIL PMZ in human plasma. 
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